HealthBeacon plc
$0.50+$0.48 (+2,269.67%)
HealthBeacon plc’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
OTC · DOCRF · USD
Stock price, earnings
Quote as of Jul 1, 2024, 01:38 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CloudMD Software & Services Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CloudMD Software & Services Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CloudMD Software & Services Inc., a Vancouver-headquartered healthcare technology firm founded in 2013, serves clients across North America. The company, which rebranded from Premier Health Group Inc. in February 2020, organizes its operations into three core divisions: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. Its extensive range of enterprise health solutions addresses critical areas such as mental well-being support, healthcare navigation, comprehensive rehabilitation and assessment programs, health education, managing employee absences, and occupational health. CloudMD also provides foundational healthcare infrastructure through its billing and electronic medical records (EMR) solutions. The company pioneers innovative digital platforms, including MyHealthAccess, a patient portal that facilitates online appointment bookings and virtual care consultations. Its sophisticated Health and Wellness platform offers a real-time intervention and prevention system capable of analyzing disparate data sources to pinpoint indicators and calculate risk scores. Further digital offerings include the iMD platform, providing access to peer-reviewed educational resources, alongside a full suite of telemedicine services. For vision care, CloudMD's VisionPros platform delivers contact lenses directly to consumers online. Beyond its digital capabilities, CloudMD maintains a physical presence, managing a network of hybrid medical and rehabilitation clinics, as well as traditional medical clinics focused on family practice and on-site patient care. The company also operates two pharmacies, retailing prescription and over-the-counter medications alongside general merchandise. Rounding out its comprehensive services, CloudMD offers patient support programs designed for holistic disease management and enhanced clinical outcomes, coupled with pharmaceutical logistics services encompassing drug distribution, patient navigation assistance, and real-time universal disease management software.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $19.27M-3.41% vs estimate |
| Q3 2022 | Nov 15, 2022 | -$0.32-1,500.0% vs estimate | $19.88M-32.89% vs estimate |
|---|
| Q2 2022 | Aug 22, 2022 | -$0.15-650.0% vs estimate | $31.29M-3.21% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.50+$0.48 (+2,269.67%)
HealthBeacon plc’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.03+$0.03 (0.0%)
Carebook Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.51% below the high.
$1.99+$0.01 (+0.3%)
Polydex Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.19% below the high.
$0.01+$0.00 (+14.62%)
SQI Diagnostics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.67% below the high.
$0.04-$0.00 (-3.31%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 68.95% below the high.
$0.04$0.00 (0.0%)
CLS Holdings USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.54% below the high.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
$0.12-$0.10 (-44.37%)
Fire & Flower Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.43% below the high.